Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 24, 2015 - Issue 1
Submit an article Journal homepage
299
Views
4
CrossRef citations to date
0
Altmetric
Review

Evaluating the Phase II drugs currently under investigation for diabetic neuropathy

Ernest AdeghateUnited Arab Emirates University, College of Medicine and Health Sciences, Department of Anatomy, P.O Box 17666, Al Ain, UAE+971 3 7672033; [email protected]
, MD PhD (Professor) ,
Erzsébet FehérSemmelweis University, Department of Anatomy, Budapest, Hungary
&
Huba KalászSemmelweis University, Department of Pharmacology and Pharmacotherapy, Budapest, Hungary
Pages 1-15 | Published online: 29 Aug 2014

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Kinga Sałat, Anna Jakubowska & Katarzyna Kulig. (2015) Cebranopadol: a first-in-class potent analgesic agent with agonistic activity at nociceptin/orphanin FQ and opioid receptors. Expert Opinion on Investigational Drugs 24:6, pages 837-844.
Read now

Articles from other publishers (3)

Mahla Daliri, Thomas P Johnston & Amirhossein Sahebkar. (2023) Statins and peripheral neuropathy in diabetic and non-diabetic cases: a systematic review. Journal of Pharmacy and Pharmacology 75:5, pages 593-611.
Crossref
Fei Ye, Zhifeng Zhang, Wenxia Zhao, Jianhai Ding, Yali Wang & Xueyan Dang. (2021) Two methods for the preparation of sitagliptin phosphate via chemical resolution and asymmetric hydrogenation . RSC Advances 11:8, pages 4805-4809.
Crossref
Feng Peng, Yonggang Chen, Cheng-yi Chen, Peter G. Dormer, Amude Kassim, Mark McLaughlin, Robert A. Reamer, Edward C. Sherer, Zhiguo J. Song, Lushi Tan, Matthew T. Tudge, Baoqiang Wan & John Y. L. Chung. (2017) Asymmetric Formal Synthesis of the Long-Acting DPP-4 Inhibitor Omarigliptin. The Journal of Organic Chemistry 82:17, pages 9023-9029.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.